Subconjunctival Bevacizumab Injection Impairs Corneal Innervations and Epithelial Wound Healing in Mice
Open Access
- 1 March 2017
- journal article
- cornea
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Opthalmology & Visual Science
- Vol. 58 (3), 1469-1477
- https://doi.org/10.1167/iovs.16-20926
Abstract
Purpose: To investigate the effects of subconjunctival bevacizumab injection on the corneal nerve, sensitivity, and epithelial wound healing in mice. Methods: Adult C57BL/6 mice were treated with subconjunctival injection of 1, 2, 5, or 25 mg/mL bevacizumab. The corneal nerve was observed with whole-mount anti-β3-tubulin fluorescence staining. Corneal sensitivity was measured with a Cochet-Bonnet esthesiometer. The protein levels of pigment epithelium-derived factor (PEDF), nerve growth factor (NGF), glial-derived neurotrophic factor (GDNF), and ciliary neurotrophic factor (CNTF) were measured by ELISA. The corneal epithelial wound-healing rate was evaluated by fluorescein staining. The recovery of impaired mouse corneal innervations and epithelial wound-healing rate following bevacizumab injection was evaluated with the co-injection of PEDF, NGF, or CNTF. Results: Subconjunctival bevacizumab injection caused apparent corneal nerve degeneration, attenuated corneal sensitivity, and delayed corneal epithelial wound healing and nerve regeneration in normal mice, which was more significant with increased concentration and times of the bevacizumab injection. However, the corneal nerve and sensitivity gradually improved and recovered in mice with a single injection of 1 to 5 mg/mL bevacizumab. Moreover, the bevacizumab injection significantly decreased the corneal PEDF, NGF, and CNTF content, whereas exogenous PEDF, NGF, or CNTF supplement attenuated impairment of the corneal nerve, sensitivity, and epithelial wound healing after subconjunctival bevacizumab injection. Conclusions: Subconjunctival bevacizumab injection impairs corneal innervations, epithelial wound healing, and nerve regeneration in normal mice, which may be caused by the reduction of neurotrophic factor content in the cornea.Keywords
This publication has 41 references indexed in Scilit:
- Vascular endothelial growth factor promotes anatomical and functional recovery of injured peripheral nerves in the avascular corneaThe FASEB Journal, 2013
- VEGF ligands and receptors: implications in neurodevelopment and neurodegenerationCellular and Molecular Life Sciences, 2013
- VEGF-A Is Necessary and Sufficient for Retinal Neuroprotection in Models of Experimental GlaucomaThe American Journal of Pathology, 2013
- Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseasesThe Journal of Biochemistry, 2012
- VEGF Mediates Commissural Axon Chemoattraction through Its Receptor Flk1Neuron, 2011
- VEGF and angiopoietin signaling in tumor angiogenesis and metastasisTrends in Molecular Medicine, 2011
- IL-17 and VEGF Are Necessary for Efficient Corneal Nerve RegenerationThe American Journal of Pathology, 2011
- Vascular Endothelial Growth Factor Mediates Corneal Nerve RepairInvestigative Opthalmology & Visual Science, 2008
- Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk‐1 receptorEuropean Journal of Neuroscience, 2000
- Vascular Endothelial Growth Factor Has Neurotrophic Activity and Stimulates Axonal Outgrowth, Enhancing Cell Survival and Schwann Cell Proliferation in the Peripheral Nervous SystemJournal of Neuroscience, 1999